147 related articles for article (PubMed ID: 29147173)
21. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
[TBL] [Abstract][Full Text] [Related]
22. Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion.
Chen M; Knifley T; Subramanian T; Spielmann HP; O'Connor KL
PLoS One; 2014; 9(2):e89892. PubMed ID: 24587105
[TBL] [Abstract][Full Text] [Related]
23. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
25. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
26. LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.
Harrison SM; Knifley T; Chen M; O'Connor KL
BMC Cancer; 2013 Oct; 13():501. PubMed ID: 24160245
[TBL] [Abstract][Full Text] [Related]
27. RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers.
Abraham HG; Ulintz PJ; Goo L; Yates JA; Little AC; Bao L; Wu Z; Merajver SD
Front Oncol; 2021; 11():712041. PubMed ID: 34513691
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
[TBL] [Abstract][Full Text] [Related]
30. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
31. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
32. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.
Zeng GF; Cai SX; Wu GJ
BMC Cancer; 2011 Mar; 11():113. PubMed ID: 21450088
[TBL] [Abstract][Full Text] [Related]
34. Specific role of RhoC in tumor invasion and metastasis.
Lang S; Busch H; Boerries M; Brummer T; Timme S; Lassmann S; Aktories K; Schmidt G
Oncotarget; 2017 Oct; 8(50):87364-87378. PubMed ID: 29152087
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
36. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
[TBL] [Abstract][Full Text] [Related]
37. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
[TBL] [Abstract][Full Text] [Related]
39. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.
Lane J; Martin TA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2008 Sep; 33(3):585-93. PubMed ID: 18695890
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
